The Treatment of Lung Involvement in Systemic Sclerosis

Systemic sclerosis (SSc) patients are often affected by interstitial lung disease (ILD) and, although there have been recent treatment advances, it remains the leading cause of death among SSc, with a 10-year mortality up to 40%. African Americans and subjects with diffuse cutaneous SSc or anti-topo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceuticals (Basel)
Main Authors: Ruaro, Barbara, Confalonieri, Marco, Matucci-Cerinic, Marco, Salton, Francesco, Confalonieri, Paola, Santagiuliana, Mario, Citton, Gloria Maria, Baratella, Elisa, Bruni, Cosimo
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7918752/
https://ncbi.nlm.nih.gov/pubmed/33668530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14020154
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados